OR WAIT null SECS
Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.
The FODMAP diet is considered a preferable option for patients with irritable bowel syndrome.
Diet might be just as important a treatment for gastrointestinal disorders like irritable bowel syndrome (IBS) as any medication is.
And until recently the advice on diet was a little unclear as there were very few studies proved the value in diet and specifics in diet for this patient population.
But recently there has been more evidence-based research proving the value in diet in not only preventing gastrointestinal disorders, but also aiding patients who have been diagnosed with diseases like IBS.
An example of a diet that has value in this target population is the FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols) diet.
This diet values whole grains, fruits, vegetables, and lean proteins like chicken and fish, while eliminating the processed sugars and sweeteners that are prevalent in many diets today.
One of the biggest advocates for this diet for patients with gastrointestinal disorders is William Chey, MD, professor of gastroenterology and nutrition sciences at Michigan Medicine at the University of Michigan.
Chey joined the DocTalk Podcast to discuss how diets like FODMAP can be beneficial for IBS patients and how should patients view food trends to avoid falling for faulty information.
He also explained how the COVID-19 pandemic may have been good for some diets, while bad for others.